ArticlePDF Available

Maternal and neonatal outcomes in HELLP syndrome, partial HELLP syndrome and severe pre-eclampsia: Eleven years experience of an obstetric center in the north of Iran

Authors:

Abstract and Figures

Objective: This study aimed to determine the maternal and neonatal outcomes in hemolysis, elevated liver enzymes and low platelets syndrome (HELLP), partial HELLP syndrome (PHS) and severe pre-eclampsia: an eleven years experience of an obstetric center in the North of Iran. Methods: This retrospective observational study was done on pregnant women admitted in the Yahyanejad Hospital in the Babol University of Medical Science during 1998-2009. A total of 327 pregnant women were categorized into three groups: severe pre-eclampsia, PHS and HELLP syndrome. Data were analyzed by appropriate tests for continuous or categorical outcomes with differences considered significant if P < 0.05. Findings: Our finding demonstrated that the rate of caesarean section, blood transfusion, acute renal failure, admitting in Intensive Care Unit and liver hematoma were significantly greater in the pregnancy with HELLP syndrome versus severe pre-eclampsia.(p<0.05). Conclusion: Maternal and neonatal morbidities increased among that HELLP syndrome. So, immediate diagnosis and proper management could be attempted to improve maternal and prenatal outcomes.
Content may be subject to copyright.
World Applied Sciences Journal 26 (11): 1459-1463, 2013
ISSN 1818-4952
© IDOSI Publications, 2013
DOI: 10.5829/idosi.wasj.2013.26.11.1280
Corresponding Author: B. Hasannasab, Department of Anesthesiology, Babol University of Medical Science, Babol, Iran.
Tel: +98-111-2274881, Fax: +98-111-2274880.
1459
Maternal and Neonatal Outcomes in HELLP Syndrome,
Partial HELLP Syndrome and Severe Pre-Eclampsia: Eleven
Years Experience of an Obstetric Center in the North of Iran
Zinatossadat Bouzari, Shiva Firoozabadi, Bahman Hasannasab,
1 23
Seyedsina Emamimeybodi and Masoume Golsorkhtabar-Amiri
14
Stem cell research center, Babol University of Medical Science, Babol, Iran
1
Obstetrics & Gynecology Department, Babol University of Medical Science, Babol, Iran
1,2
Anesthesiology Department, Babol University of Medical Science, Babol, Iran
3
Fatemezahra Infertility and Reproductive Health Research center,
4
Babol University of Medical Science, Babol, Iran
Submitted: Sep 2, 2013; Accepted: Oct 8, 2013; Published: Dec 2, 2013
Abstract: Objective: This study aimed to determine the maternal and neonatal outcomes in hemolysis, elevated
liver enzymes and low platelets syndrome (HELLP), partial HELLP syndrome (PHS) and severe pre-eclampsia:
an eleven years experience of an obstetric center in the North of Iran. Methods: This retrospective observational
study was done on pregnant women admitted in the Yahyanejad Hospital in the Babol University of
Medical Science during 1998-2009. A total of 327 pregnant women were categorized into three groups: severe
pre-eclampsia, PHS and HELLP syndrome. Data were analyzed by appropriate tests for continuous or
categorical outcomes with differences considered significant if P < 0.05. Findings: Our finding demonstrated
that the rate of caesarean section, blood transfusion, acute renal failure, admitting in Intensive Care Unit
and liver hematoma were significantly greater in the pregnancy with HELLP syndrome versus severe
pre-eclampsia.(p<0.05). Conclusion: Maternal and neonatal morbidities increased among that HELLP syndrome.
So, immediate diagnosis and proper management could be attempted to improve maternal and prenatal
outcomes.
Key words: HELLP Syndrome Preclamcia Partial HELLP Syndrome
INTRODUCTION The HELLP syndrome is characterized by the
Hypertensive disorders of pregnancy were the most HELLP syndrome (PHS) consists of only one or two
common medical complication that occurs in 5-10% of all elements of the triad [6]. Although, the incidence of
pregnancies [1-2]. Among the types of gestational HELLP syndrome varies from 2 to 12%, 5-20% of the
hypertension, pre-eclampsia is the most dangerous form patients with HELLP syndrome are associated with
is associated with proteinuria [2]. Pre-eclampsia is a hypertension and proteinuria [7]. The incidence of PHS is
multisystem disorder with unknown etiology that can greater and is probably estimated from 21 to 24 % [8].
observe as eclampsia or HELLP syndrome (hemolysis, Maternal outcome in HELLP syndrome include: hepatic
elevated Liver enzymes and low platelets) [3]. The HELLP rupture, acute renal failure (ARF), disseminated
syndrome is a serious health hazard during pregnancy intravascular coagulation (DIC), abruption placenta,
[1-4] and 60% of cases are required delivery by cesarean pulmonary and cerebral edema, intracranial hemorrhage
section [5]. and hypovolemic shock [7, 3]. Prenatal outcomes such as
presence of all three major components, while partial
World Appl. Sci. J., 26 (11): 1459-1463, 2013
1460
respiratory distress syndrome (RDS), intra uterine growth pre-eclampsia was defined as a blood pressure 160/90
restriction (IUGR) and intra uterine Fetal death (IUFD) mm Hg and proteinuria 2 in dipstick or proteinuria of at
were reported about 7.7- 60% in preterm delivery [9]. In a least 2g/24 h, intrauterine fetal growth restriction,
quest were reported patients with a history of HELLP are persistent headache, persistent of epigastric pain, serum
at the increased risk for preeclampsia and HELLP is creatinin levels >1.2 mg/dl and visual disturbances but
associated with long-term morbidities such as depression without alterations in laboratory tests for HELLP
and chronic hypertension [10]. syndrome. HELLP syndrome is characterized based on
Present study aimed to determine maternal and three criteria, including: thrombocytes < 100,000 mm ,
prenatal outcomes of HELLP syndrome and PHS, because aspirate aminotransferase (AST) >70 UI/L, lactate
there is a little information about it in the north of Iran. dehydrogenase (LDH) > 600 UI/L and PHS was defined by
Then we compare maternal and prenatal outcomes the presence of one or two of these parameters. Maternal
between women with HELLP syndrome, PHS and women and neonatal data recorded in the records were reviewed
who have sever pre-eclampsia but normal laboratory tests for maternal outcome such as hepatic rupture, ARF, DIC,
for HELLP syndrome. abruption placenta, pulmonary edema, cerebral edema,
MATERIALS AND METHODS outcomes such as RDS, IUGR and IUFD. Statistical
This retrospective observational study done among Fisher´s Exact test and statistical significance was
admitted the patients in the Yahyanejad Hospital in considered at p< 0.05.
the Babol Medical University during 1998 and 2009.
We reviewed maternal and neonatal medical charts in RESULTS
women who were admitted with a diagnosis of sever
pre-eclampsia, HELLP syndrome and PHS. Exclusion In this retrospective study, out of 375 patients during
criteria included multiple pregnancy, fetal anomalies and 11year with severe pre-eclampsia, HELLP syndrome and
patients with renal and liver disease, pre-eclampsia with PHS after applying the exclusion criteria, 309 patients with
PHS or HELLP syndrome and hematological diseases. severe pre-eclampsia, HELLP syndrome and PHS were
Gestational age was determined from the first day in the enrolled and their maternal and neonatal outcomes were
last menstrual period (LMP), if women were unsure their noted . 89(28.8%) patients with severe pre-eclampsia, 203
LMP, the gestational age was used to the findings of a (65.7%) patents with PHS and 17(55.7%) patients with
dating ultrasound scan that had been done before 20 HELLP syndrome remained for the study. The mean age
weeks of pregnancy. in our patients was 26.59±5.85. The Maternal demographic
We received the ethic permission from the ethic and clinical characteristics for severe pre-eclampsia, PHS
committee of Babol University of Medical Science. and HELLP are shown in Table 1. We found the parity
Patients were categorized into three groups: severe greater than one in 31 cases (34.8%) of the severe
pre-eclampsia, HELLP syndrome and PHS. Severe pre-eclampsia and 73 cases (36%) of the PHS and also,
3
intracranial hemorrhage, hypovolemic shock and prenatal
analyses were performed with the chi-square test and
Table 1: Maternal demographic and clinical characteristics in the three grousp under study
Severe pre-eclampsia Partial HELLP syndrome HELLP syndrome
N=89 N=203 N=17 P-Value
Age(yr) 26.39±5.69 26.67±6.03 26.65±4.76 0.93
Gravidity (%)
1 50(56.2) 113(55.7) 8(47.1) 0.77
2 39(43.8) 90(44.3) 9(52.9)
Parity (%)
0 58(65.2) 130(64) 5(29.4) 0.015
1 31(34.8) 73(36) 12(70.6)
Gestational age at delivery (wk) 35.83±3.61 35.84±2.94 33.76±2.58 0.031
Birth Weight (gr) 2582.06±907.13 2855.02±1267.67 1973.52±747.7 0.004
Sig is P<0.05
PHS; Partial HELLP Syndrome
HELLP; Hemolysis, Elevated Liver enzymes and Low Platelets
World Appl. Sci. J., 26 (11): 1459-1463, 2013
1461
Table 2: Comprison of maternal and neonatal outcome in pregnancy in the three groups
Maternal neonatal outcomes Severe pre-eclampsia N (%) PHS N (%) HELLP syndrome N (%) P-Value
IUFD 3(3.4) 3(1.5) 0(0.0) 0.46
IUGR 5(5.6) 10(4.9) 3(17.6) 0.098
FD 6(6.7) 11(5.4) 3((17.6) 0.02
Preterm labor 48(3.9) 102(50.2) 3(17.6) 0.022
NICU 20(22.5) 41(20.2) 3(17.6) 0.86
Neonatal mortality 0(0) 0(0) 0(0) 0(0)
Sex
Male 80(89) 176(86.7) 11(64.7) 0.021 1 ver 3, 2 ver 3
Female 9(10.1) 27(13.3) 6(35.3)
Induction of labor 36(40.4) 88(43.3) 11(64.5) 0.179
Cesarean section 3(3.4) 6(3) 4(23.5) <0.001 1 ver 3, 2 ver 3
Blood transfusion 0(0) 7(3.4) 4(23.5) <0.001 1 ver3, 2 ver 3, 1 ver 2 ver 3
Postpartum hemorrhage 0(0) 3(1.5) 1(5.9) 0.134
ARF 0(0) 0(0) 2(11.8) <0.001 1 ver 3, 2 ver 3
Need to ICU 0(0) 1(0.5) 2(11.8) <0.001 1 ver 3, 2 ver 3
Abruption placenta 8(9) 13(6.4) 3(17.6) <0.22
Maternal death 0(0) 0(0) 1(5.9) <0.001 2 ver 3
liver hematoma 1(1.1) 3(1.5) 4(23.5) <0.001 1 ver 3, 2 ver 3
Pulmonary edema 0(0) 0(0) 1(5.9) <0.001
Eclamcia 2(2.2) 2(1) 1(5.9) <0.263
Sig is P<0.05
PHS; partial HELLP Syndrome
HELLP; Hemolysis, Elevated Liver enzymes and Low Platelets
12(70.6%) of the HELLP syndrome. It revealed a DISCUSSION
significant difference between the three groups (p=0.015)
on behalf of the HELLP group. The mean of gestational Pre-eclampsia, PHS and HELLP syndrome are a
age in our patients was 35.72±3.15 wk. The gestational age life –threatening complication in the pregnancy. In the
at delivery and birth weight were lower significantly in the current study, indication for caesarean section, blood
women with HELLP syndrome versus other groups. transfusion, acute renal failure, need to ICU care and liver
(P<0.031 and P<0.004 respectively). hematoma displayed significantly greater in the women
Table 2 described the comparison of maternal and with the HELLP syndrome versus PHS and Pre-eclampsia.
neonatal outcomes in the pregnant women with severe Some queries are inconsistence with our findings.
pre-eclampsia, PHS and HELLP syndrome. Maternal and Gul et al reported perinatal mortality and neonatal
neonatal outcomes in the pregnant women with severe morbidity-mortality is nonsinificant in HELLP syndrome
pre-eclampsia versus PHS are not shown the statistical with severe preeclampsia-eclampsia without HELLP.
significant differences in any variables. Gul interpreted it is according to gestational age before
Also, the comparison of maternal and neonatal and after the 32nd week [11]. Whereas, the mean of
outcomes of the PHS syndrome with HELLP syndrome in gestational age in our patients was 35.72±3.15 wk and also
the pregnant women were shown that the indication for regarding the enhancement of the gestational
caesarean section, blood transfusion, maternal death, consequences which synchronizes by growing pregnancy
ARF, need to Intensive care unit (ICU) and liver in these patients, hence, we contemplate diversity of Gul
hematoma were significantly higher in the pregnancies et al findings with us seems rationale.
with HELLP syndrome versus PHS (p<0.05). (Table 2). The maternal and neonatal morbidities enhanced
Additionally, significant differences were displayed among our patients with the HELLP syndrome.
in the cesarean section, blood transfusion, ARF, maternal Khumsat et al divided the patients in two groups: sever
death, liver hematoma, pulmonary edema and need to ICU preclamcia and HELLP syndrome. Preterm delivery and
care among the three groups. eclamcia showed nonsignificant differences between
It is interesting in our research that 80(89%) of the two groups [9]. However, in Keiser' experience,
infants of preclamcia women and 176(86.7) of PHS were eclampsia does not seem to apply a significant adverse
male which demonstrated a significantly difference versus influence upon the outcome of HELLP syndrome
HELLP women. pregnancies [12].
World Appl. Sci. J., 26 (11): 1459-1463, 2013
1462
We found no significant difference between patients Evaluation of the women complicated with HELLP
age in the pregnant women with sever re-eclampsia, PHS syndrome in the multi prenatal centers of a region is
and HELLP syndrome similar to some studies [7, 8]. suggested for investigate the interference environmental
However, Khumsat and his colleagues resulted women elements.
with HELLP syndrome were significantly older.
Nevertheless, multiparty and lower gestational age were CONCLUSION
significant in the HELLP women in his study and us [9].
Our finding is also according to Vigil et al. and Habi et al. We found maternal and neonatal morbidities
which reported gestational age can be considered a enhanced among the women complicated with HELLP
predictor for long-term consequences at the beginning of syndrome. So, immediate diagnosis and proper
HELLP [13]. management could be attempted to improve maternal and
Also in our research, the preterm labor in pregnant prenatal outcomes.
women with pre-eclampsia, PHS and HELLP syndrome
demonstrated significant difference, although it showed Conflict of Interest: The vice chancellor of Research and
no significant difference within the groups, while Technology of Babol University of Medical Science
Guzel et al. concluded fetal prematurity and low birth assisted us financially.
weight were significantly associated with fetal mortality in
the HELLP syndrome, so he recommended the prevention ACKNOWLEDGEMENT
of prematurity as a prime priority for the fetus in
pregnancies involved with the HELLP syndrome [14]. We hereby thanks to all staffs of labor and delivery
We guess our difference with Guzel is in the small size of rooms of Yahyanejad Hospital for their cordially
sever preclamcia women in his study. contribution.
Analysis of our data demonstrated that the rate of
caesarean section and blood transfusion was greater in REFERENCE
pregnancy with PHS than HELLP syndrome, however,
ARF, admitted in ICU and liver hematoma was greater in 1. Scott, J.R., R.S. Gibbs, B.Y. Karlan, A.F. Haney and
pregnancy with HELLP syndrome than PHS. These results D.N. Danforth, 2008. Danforth's Obstetrics and
are accordance with Abbade et al. and also, Khumsat Gynecology, 2008. Lippincott Williams & Wilkins
et al. studies. [8, 9]. Additionally, we found the rate of Publishers; 10th ed. New York (NY), pp: 147.
caesarean section, blood transfusion, ARF, admitted in 2. Cunningham, G.F, 2005. Screening for osteoporosis.
ICU and liver hematoma were significantly higher in the N Engl J. Med. 353(18): 1975; author reply 1975.
pregnancies with severe pre-eclampsia and HELLP 3. Yucesoy, G., S. Ozkan, et al, 2005. Maternal and
syndrome. Khumsat and Liu [9, 15]. revealed the same perinatal outcome in pregnancies complicated with
results. hypertensive disorder of pregnancy: a seven year
The treatment of patients with pre-eclampsia and PHS experience of a tertiary care center. Arch Gynecol
and HELLP syndrome are in conflict. Pokharel believed Obstet, 273(1): 43-49.
that the exact diagnosis of HELLP syndrome and the 4. Adukauskiene, D., V. Vizgirdaite, et al, 2006.
immediate approach is so necessary in an obstetrics [Hemolysis, elevated liver enzymes and low platelet
center. We contemplate the management of patients count syndrome]. Medicina (Kaunas), 42(9): 695-702.
with pre-eclampsia and PHS is controversial. 5. Pokharel, S.M., S.K. Chattopadhyay, et al, 2008.
Abbade suggested prompt intervention enhances the "HELLP syndrome--a pregnancy disorder with poor
cesarean rates and preterm delivery in PHS syndrome. prognosis. Nepal. Med. Coll J., 10(4): 260-263.
He emphasized the women with PHS involved with some 6. Haram, K., E. Svendsen, et al, 2009. The HELLP
problems, however not as vigorous as in HELLP syndrome: clinical issues and management. A
syndrome" and any aggressive and hastily procedures Review. BMC Pregnancy Childbirth, 9: 8.
rare resulted to worsening of the maternal and prenatal 7. Yucesoy, G., Y. Cakiroglu, et al, 2011. An analysis of
outcomes. So, we also agree with him who recommended HELLP syndrome cases: does platelet count predict
any decisions should make with caution and monitoring. adverse maternal and fetal outcomes in women
Our study limitation was small sample size for HELLP with HELLP syndrome? Arch Gynecol Obstet,
syndrome which may beget a bias in the whole statistics. 283(5): 941-945.
World Appl. Sci. J., 26 (11): 1459-1463, 2013
1463
8. Abbade, J.F., J.C. Peracoli, et al., 2002. Partial HELLP 12. Keiser, S.D., M.Y. Owens, et al., 2011. HELLP
Syndrome: maternal and perinatal outcome. Sao Paulo syndrome with and without eclampsia. Am J.
Med J., 120(6): 180-184. Perinatol., 28(3): 187-194.
9. Khumsat, R., T. Wongwananurak and 13. Vigil-De Gracia, P., 2001. Pregnancy complicated by
D. Boriboonhirunsarn, 2008. Incidence and Risk pre-eclampsia-eclampsia with HELLP syndrome. Int.
Factors of HELLP Syndrome in Thai Pregnant J. Gynaecol. Obstet., 72(1): 17-23.
Women with Severe Pre-eclampsia. Thai Journal of 14. Guzel, A.I., U. Kuyumcuoglu, et al., 2011. Are
Obstetrics and Gynaecology, 16(192): 19861-67. maternal and fetal parameters related to perinatal
10. Habli, M., N. Eftekhari, et al, 2009. Long-term mortality in HELLP syndrome? Arch Gynecol.
maternal and subsequent pregnancy outcomes 5 Obstet., 283(6): 1227-1232.
years after hemolysis, elevated liver enzymes and low 15. Liu, C.M., S.D. Chang, et al, 2006. Comparisons of
platelets (HELLP) syndrome. American journal of maternal and perinatal outcomes in Taiwanese women
Obstetrics and Gynecology, 201(4): 385 e381-385. with complete and partial HELLP syndrome and
11. Gul, A., A. Cebeci, et al., 2005. Perinatal outcomes in women with severe pre-eclampsia without HELLP.
severe preeclampsia-eclampsia with and The journal of Obstetrics and Gynaecology Research,
without HELLP syndrome. Gynecol Obstet Invest 32(6): 550-558.
59(2): 113-118.
... Although there is universal agreement on a clear association between c-HELLP syndrome and maternal mortality, 1.1% as reported by Sibai et al. [15], this can vary widely depending on the population studied, the diagnostic terms used and the presence of associated pre-existing medical conditions [16]. Maternal mortality rate ranged between 0.0 and 35.4% [5,10,11,17,18]. This variance in maternal mortality and other complications might reflect differences in prenatal care, hospital accessibility, inappropriate diagnostic and management protocols applied to these patients, such factors being more frequent in developing countries [16]. ...
... Maternal mortality is more prevalent in, but not limited to, patients with c-HELLP. Individual studies have reported 2.2%, 6.25% and 15.3% maternal mortality among patients with p-HELLP, which bears witness to the hazards that can complicate p-HELLP [11,17,18]. As in c-HELLP syndrome, all kinds of catastrophic morbidities can occur, including intracranial hemorrhage and liver hematoma, albeit at a lower frequency. ...
... We noted also that vaginal delivery, NICU admission rate, prevalence of IUFD and lower mean birth weight tended to be higher in the group with c-HELLP syndrome. This pattern was also seen in other studies [5,10,[17][18][19]. This might indicate that c-HELLP tends to be more severe and affects the uteroplacental blood supply more, thus mandating delivery at an earlier gestational age. ...
Article
Full-text available
To compare short-term outcomes at index and subsequent pregnancies, as well as the long-term medical complications encountered later than 5 years after index pregnancy incomplete and partial HELLP syndromes. Pregnancies complicated by partial HELLP or complete HELLP during a period of 19 years were identified. Searches were limited to cases before 2012 to ensure an adequate follow-up period. Data on index or subsequent pregnancies occurring at our center were extracted from the hospital database, while data pertaining to subsequent obstetric outcomes when deliveries occurred elsewhere together with current medical conditions were acquired by patient self-reporting. Complete HELLP was defined as the presence of the 3 components of the syndrome whereas partial HELLP was defined by the presence of 1 or 2 components. 100 pregnancies were included. At index pregnancy, there was a higher rate of composite adverse maternal outcome in complete HELLP when compared to partial HELLP (45.8% vs 21.1%, p = 0.017). Outcomes at subsequent pregnancies showed no difference between the two variants of HELLP syndrome. When examined years later, a higher frequency of “composite medical morbidity” in the complete HELLP group was observed, though this difference did not reach statistical significance (77.7% vs 61.9%, p = 1.00). Although partial HELLP is relatively less harmful, it can nonetheless cause serious maternal complications including ruptured liver hematoma, intracranial hemorrhage and even mortality. These two clinical entities represent a continuum of the same pathology, which implies that the approach at management should be uniform. Furthermore, the prognosis and long-term outcomes were not different between these 2 variants.
... In our study, Mean gestational age was 38.42 ± 1.69 weeks which was similar to studies conducted by Chauhan V et al. [7] (38.6 ± 1.34weeks), Sojitra M et al. [4] (38 weeks) and Lin et al. [8] (39 weeks). Where as in the study by Bouzari et al. [9] the mean age was 35.83 ± 3.61 weeks which was lower than our study. In our study maximum cases 71% belonged to gestational age 37 to 40 week which was similar to Parnas et al. [10] . ...
... In my study maternal mortality was 1% which was similar to study done by Sibai et al. [17] (1.1%). The mean weight of neonates born to the women enrolled in our study was 2.58 ± 0.49 kg which was similar to study by Bouzari et al. [9] (2.58 ± 0.8kg) whereas the mean weight was higher in study by Chauhan V et al. [7] (2.80 ± 0.32kg) and Onisai et al. [18] (2.9 ± 0.23 kg) as we included patients with hypertensive disorders (HELLP, preeclampsia, eclampsia, gestational hypertension and superimposed preeclampsia). Majority of newborn 76.47% (78) had normal birth weight and 23.53% (24) had low birth weight which was comparable to study reported by Chauhan V et al. [7] in which 92.3% had normal weight and only 7.7% had low birth weight. ...
... In the present study, the mean gestational age at delivery was 37.20±2.24 weeks which is similar to the study conducted by Lin et al. [9] and Kasai et al. [28] (39 weeks and 38 weeks respectively) whereas in the study conducted by Bouzari et al. [29] the mean age was 35.83±3.61 weeks which was lower than our study because in their study they analysed only patients with severe pre-eclampsia and HELLP syndrome. ...
... (kgs) which is similar to the mean neonatal weight in the study conducted by Onisai et al. [7] (2.9±0.23 kgs) and Chauhan et al. [11] (2.80±0.32 kgs), whereas the mean weight was lower in study by Bouzari et al. [29] (2.58±0.8 kgs) as they included patients of only hypertensive disorder (HELLP, pre-eclampsia and eclampsia). ...
... weeks which was lower than our study. 26 The mean platelet count in present study was 106907.7±30136.52/µL. In the study conducted by Singh et al mean platelet count was 110320+21345.4/µL ...
... kg). 26 In our study 6.15% neonates required NICU admissions. In the study conducted by Vyas et al 13.20% neonates were admitted to NICU. 9 In the study by Lin et al, 0.30% neonates required NICU admission which is very low as compare to our study. ...
... which agrees with previous studies. 11,12 Hypertensive Disorders in Pregnancy (HDP) is the most prevalent maternal complication worldwide as it affects 7-10% of all pregnancies and it is associated with a significant maternal and fetal morbidity and mortality. Perinatal morbidity and mortality usually result from intrauterine growth restriction (IUGR) due to uteroplacental insufficiency and complications related to prematurity. ...
Article
Full-text available
Background: The (HELLP) syndrome is a severe health hazard in pregnancy described by elevated liver enzymes, low platelet count and hemolysis. It happens in 0.4 to 0.7% of all gestations and in 10-12% of cases with severe preeclampsia. Patients and methods: The present study was a prospective observational study that was made at Department of Obstetrics and Gynecology, Kasr Al-Ainy University Hospital, Cairo University, from September 2018 – March 2019. It included One Hundred and Thirty pregnant women diagnosed with hypertension in the current pregnancy complicated with severe preeclampsia, or HELLP Syndrome associated with abdominal ascites, recruited from the attendees of the Obstetric Emergency Department. The study was approved by the local institutional review board of the Faculty of Medicine, Cairo University. All ladies signed an informed consent. Results: There were statistically significant differences between the HELLP group and the severe preeclamptic group regarding maternal ICU admission and the need of multiple drugs to control the blood pressure being less in severe preeclampsia group. The need for ICU admission was much higher in the HELLP group (43.1%) compared to the severe preeclampsia group (9.2%) showing statistical significance (P<0.001). Conclusion: Maternal and neonatal sicknesses are elevated between cases with HELLP syndrome. So, early diagnosis and definitive treatment can be made to enhance maternal and neonatal results.
Article
Full-text available
Aims: To study thrombocytopenia in pregnancy and its correlation with fetomaternal outcome in a tertiary care centre.
Article
Full-text available
Background: Thrombocytopenia is second most common haematological abnormality in pregnancy after anemia. The aim of this study was to find out the prevalence, causative factor of thrombocytopenia and to observe the obstetrics outcome of pregnancies complicated with thrombocytopenia.Methods: This is prospective study of maternal outcome in pregnancy with thrombocytopenia carried out at tertiary care center from February 2019 to January 2020. Out of 350 antenatal screened women, 25 women who were diagnosed with thrombocytopenia, were included in the study.Results: The incidence of maternal thrombocytopenia in this study was 7.1%. 60% of the women had mild thrombocytopenia while 24% and 16% of women were moderate and severe thrombocytopenic respectively. Amongst 25 thrombocytopenic women 68% had gestational thrombocytopenia, 24% had gestational hypertensive disorder,4% had HELLP syndrome, 4% had immune thrombocytopenic purpura. 60% were delivered vaginally and 40% were delivered by LSCS. The most common indication of LSCS was acute fetal distress (40%) followed by failed induction (30%), breech (10%), and the rest (20%) for other obstetrical indications. The most common indication for induction was pre-eclampsia followed by IUGR, and post-date.Conclusions: In pregnancy with thrombocytopenia, gestational thrombocytopenia is the commonest and benign condition which does not alter the obstetrical management. Still a vigil 4 should be kept on maternal platelet count in antenatal period to prevent unfavorable outcome in serious conditions that may require specific and urgent management (HELLP syndrome, severe pre-eclampsia, ITP).
Article
Full-text available
HELLP syndrome is a pregnancy-specific disorder defined by hemolysis, elevated liver enzymes and low platelet count that is found in parturients, more frequent in older multiparas. It is frequently associated with severe preeclampsia or eclampsia, but can also be diagnosed in the absence of these disorders. The etiology of HELLP syndrome is unknown, and the pathogenesis of this disorder (including the hepatological manifestations) is not fully understood. The most widely accepted hypotheses are: a change in the immune feto-maternal balance, platelet aggregation, endothelial dysfunction, arterial hypertension and an inborn error of the fatty acid oxidative metabolism. Hepatic involvement occurs by intravascular fibrin deposition and hypovolemia. Serum LDH and platelet count are the two most important clinical tools for disease assessment. LDH reflects both the extent of hemolysis and hepatic dysfunction. Maternofetal complications cause a 7.0-70.0% perinatal mortality rate and a 1.0-24.0% maternal mortality rate. The recognition of HELLP syndrome and an aggressive multidisciplinary approach and prompt transfer of these women to obstetric centers with expertise in this field are required for the improvement of materno-fetal prognosis.
Article
Full-text available
HELLP syndrome is a severe complication of pregnancy characterized by hemolysis, elevated liver enzymes and low platelet count. Some pregnant women develop just one or two of the characteristics of this syndrome, which is termed Partial HELLP Syndrome (PHS). The objective of this study was to evaluate the repercussions on maternal and perinatal outcomes among women that developed PHS and to compare these women with those whose gestational hypertension or preeclampsia did not show alterations for HELLP syndrome in laboratory tests. Observational, retrospective and analytical study. Maternity Department of Hospital das Cl nicas, Faculdade de Medicina de Botucatu, Universidade Estadual Paulista, Botucatu, S o Paulo, Brazil. Pregnant or post-delivery women who had a blood pressure elevation that was first detected after mid-pregnancy, with or without proteinuria, between January 1990 and December 1995. Analysis was made of maternal age, race, parity, hypertension classification, gestational age at the PHS diagnosis, alterations in laboratory tests for HELLP syndrome, time elapsed to discharge from hospital, maternal complications, mode of delivery, incidence of preterm birth, intrauterine growth restriction, stillborn and neonatal death. Three hundred and eighteen women were selected; forty-one women (12.9%) had PHS and 277 of them (87.1%) did not develop any of the alterations of the HELLP syndrome diagnosis. Preeclampsia was a more frequent type of hypertension in the PHS group than in the hypertension group. None of the women with isolated chronic hypertension developed PHS. The rate of cesarean delivery, eclampsia, and preterm delivery was significantly greater in the PHS group than in the hypertension group. We observed that aggressive procedures had been adopted for patients with PHS. These resulted in immediate interruption of pregnancy, with elevated cesarean rates and preterm delivery. Such decisions need to be reviewed, in order to reduce the cesarean rate and the incidence of preterm delivery.
Article
Full-text available
To analyze the variations between maternal complications and perinatal outcome among women with complete hemolysis, elevated liver enzyme levels, and low platelet count (HELLP) syndrome, partial HELLP syndrome, and women with severe pre-eclampsia and normal laboratory tests. We also examine the effect of corticosteroid therapy for treatment of HELLP. In this retrospective study, six patients with complete HELLP syndrome and 46 with partial HELLP syndrome, were compared and contrasted with 212 patients with severe pre-eclampsia but without HELLP syndrome. In Protocol 1, multiple organ dysfunction syndrome (MODS) was the strongest morbidity factor associated with patients among complete HELLP, partial HELLP, and severe pre-eclampsia. After post-hoc analysis, disseminated intravascular coagulation (DIC) was the significant outcome variable between complete and partial HELLP. In Protocol 2, after adjustment, we found that MODS (adjusted OR, 15.2, 95% CI, 6.18-35.53; P < 0.001); Apgar score less than 5 at 1 minute (adjusted OR, 2.17, 95% CI, 0.94-5.01; P = 0.069) and DIC (adjusted OR, 9.51, 95% CI, 1.68-53.7, P = 0.011) remained significantly associated with HELLP syndrome. There was a favorable outcome found in the complete HELLP group. Neither the dexamethasone group nor the aggressive therapy group could benefit from the treatment protocol. The different categories of HELLP syndrome, the protocol 1 and protocol 2 have been noted as differential effects on pregnancy outcome. MODS and DIC would be two significant outcome variables and corticosteroid therapy may not benefit HELLP patients.
Article
We assessed pregnancy outcomes for patients with HELLP syndrome (hemolysis; elevated liver enzymes; low platelet count) with and without concurrent eclampsia. We performed a retrospective investigation of data spanning three decades of patients with class 1 or 2 HELLP syndrome with concurrent eclampsia (HELLP + E) and patients with HELLP syndrome without eclampsia. Data were analyzed by appropriate tests for continuous or categorical outcomes with differences considered significant if P < 0.05. During 1981 to 1996 and 2000 to 2006, there were 693 patients with class 1 or 2 HELLP syndrome; altogether, 70 patients had HELLP + E. The only demographic difference was greater nulliparity in HELLP + E patients. Otherwise, inconsistent and clinically insignificant differences were observed between groups. Despite the relatively large size of the study groups, we were unable to detect a significant worsening of maternal or perinatal outcome in HELLP + E patients compared with HELLP patients. In our experience, eclampsia does not appear to contribute a significant adverse impact upon the course or outcome of HELLP syndrome pregnancies.
Article
We designed this retrospective study to evaluate the association between maternal and fetal parameters and perinatal mortality in hemolysis, elevated liver enzymes, and low platelet count (HELLP) syndrome. In this retrospective study, 152 pregnancies complicated with HELLP syndrome were evaluated. Risk factors recorded were maternal age, gravidity, gestational age (weeks), systolic and diastolic blood pressure, platelet count, alanine aminotransferase (ALT), aspartate aminotransferase (AST), lactate dehydrogenase (LDH), fetal weight, and Apgar scores. The association of these factors with perinatal mortality was determined. Statistical analyses were performed using the Chi-square (χ (2)) test with Yates' correction, the Student's t test, logarithmic transformation, and the logistic regression method. Ninety-two (60.52%) patients had mild preeclampsia, 46 (22.2%) had eclampsia, and 14 (15.2%) had severe preeclampsia. The fetal mortality rate was higher in eclamptic and severe preeclamptic patients (P = 0.029). No correlation was found between maternal age, laboratory values (platelet count, ALT, AST, and LDH), or systolic and diastolic blood pressure and fetal morbidity. According to the logistic regression model, fetuses with prematurity, low birth weight, and low Apgar scores (Apgar score 1 ≤ 3 and Apgar score 5 ≤ 5) were found to be at significant risk for perinatal mortality (P < 0.001). The odds ratios (95% CI) were 3.0 (2-5), 3.42 (1.82-6.41), 0.62 (0.44-0.86) and 4.66 (2.04-10.63), respectively. Maternal laboratory and clinical parameters were not associated with fetal mortality. Fetal prematurity, low birth weight, and low Apgar scores were significantly associated with fetal mortality. The HELLP syndrome and severe preeclampsia may be life threatening to the mother; therefore, the accepted treatment is expeditious delivery. Our study indicates that prevention of prematurity must be the main priority for the fetus in pregnancies complicated by the HELLP syndrome. This can be efficaciously achieved using glucocorticoid therapy for lung maturity and ensuring that delivery is at an experienced hospital with a multidisciplinary approach including a neonatal intensive care unit.
Article
To evaluate the maternal and fetal outcome in 44 pregnancies complicated with HELLP syndrome and to investigate the role of platelet counts in its prognosis. A retrospective analysis of the medical records of 44 patients with the diagnosis of hemolysis elevated liver enzymes and low platelet count between June 1997 and January 2009 was performed. The patients were divided into two groups according to blood platelet count: platelet count <50,000 mm(3) formed Group I and platelet count 50,000-100,000 mm(3) formed Group II. Clinical findings and laboratory characteristics, maternal complications, perinatal outcomes and comparison of maternal and fetal morbidity according to platelet counts were analyzed. During the period of 12 years, 44 (0.54%) of 8,132 deliveries had HELLP syndrome. Among 44 patients, the most common complications were disseminated intravascular coagulopathy (18.2%), acute renal failure (15.9%), abruptio placentae (11.4%), and cerebral hemorrhage/infarction (11.4%). Maternal and perinatal mortality rates in HELLP syndrome were 9.1 and 40.9%, respectively. Aspartate aminotransferase levels were found to be statistically significantly higher in Group I (p = 0.04). While disseminated intravascular coagulopathy and acute renal failure were statistically significantly higher in Group I (p = 0.01; p = 0.03 respectively), fetal growth restriction was statistically significantly higher in Group II (p = 0.04). HELLP syndrome is associated with high incidences of maternal and fetal morbidity and mortality and patients with low platelet counts might have a much increased risk.
Article
To evaluate subsequent pregnancy outcome and impact of gestational age at onset of HELLP on long-term prognosis after HELLP over an average follow-up of 5 years One hundred twenty-eight patients with a history of HELLP filled out questionnaires and sent their medical records. Hemolysis, elevated liver enzymes, and low platelets data were stratified according to gestational age at onset of HELLP < or =28 weeks and >28 weeks. Fifty-three patients had subsequent pregnancies with 24% complicated by HELLP and 28% by preeclampsia. During follow-up, 33% of the patients had new onset hypertension develop, 32% had depression develop, 26% had anxiety develop, and 2.4% required dialysis. There was no significant difference in long-term outcome between comparison groups. Patients with a history of HELLP are at increased risk for preeclampsia and HELLP as well as long-term morbidities as depression and chronic hypertension. Gestational age at the onset of HELLP could be a predictor for long-term outcome.
Article
To determine the incidence of, and assess the relationship between liver enzymes and platelet counts with the severity of HELLP (hemolysis elevated liver enzymes and low platelet count) syndrome, and describe incidences of serious maternal complications. Retrospective descriptive study of patients with pre-eclampsia-eclampsia complicated by HELLP syndrome that occurred over a 3-year period in Panama. The primary outcome included: platelet count; serum aspartate aminotransferase; serum alanine aminotransferase; symptoms and complications among class 1, 2, and 3 HELLP. There were 558 pregnancies complicated by severe pre-eclampsia and 26 by eclampsia. The incidence of HELLP syndrome among women with severe pre-eclampsia in our population was 12% and among women with eclampsia was 34.6%, (P<0.0008); with a total incidence of 16%. Epigastric pain, visual symptoms and hematuria increased with the severity of HELLP syndrome. Hematuria was the fourth symptom, but was significantly (P=0.002) associated with class 1 HELLP. There were significant differences in the platelet count, and liver enzymes among the classes of HELLP syndrome. Abruptio placentae, acute renal failure and disseminated intravascular coagulation were the most frequent maternal complications. There were two maternal deaths. This study supports the theory that HELLP syndrome is associated with increased maternal morbidity and mortality. Our data suggest that certain subgroups of patients with class 1 HELLP syndrome ('classic or true HELLP') are at increased risk for serious maternal complications, including those with: platelet counts below 50000/microl; lactic dehydrogenase> or = 2000 IU/l; aspartate aminotranferase> or = 500 IU/l; alanine aminotransferase> or = 300 IU/l; and hematuria.
Article
HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome is a severe, life-threatening pregnancy pathology, which occurs in 0.2-0.8% of all pregnancies, and approximately 10% (2-20%) of pregnancies are complicated with severe preeclampsia. This syndrome usually develops in the third trimester of pregnancy in preeclamptic patients, sometimes it occurs in the second trimester of pregnancy, and very rarely HELLP syndrome may develop within 48-72 hours after delivery. Diagnosis is complicated as there are no specific clinical signs, therefore, this syndrome may be confused with other pathologies like acute fatty liver of pregnancy, idiopathic thrombocytopenia, hemolytic uremic syndrome, appendicitis, and etc. The patients with HELLP syndrome should be treated in the tertiary care hospital, where appropriate diagnostics and multidisciplinary help for mother and fetus can be assured. When the syndrome was described for the first time, L. Weinstein recommended prompt delivery as the only possible treatment. Current studies show that conservative treatment of patients with HELLP syndrome is safe, without an increase in morbidity and mortality. That is why now many authors agree that treatment approach should be based on the estimated gestational age and the condition of the mother and fetus.
Comparisons of platelets (HELLP) syndrome. American journal of maternal and perinatal outcomes in Taiwanese women
  • M Habli
  • N Eftekhari
Habli, M., N. Eftekhari, et al, 2009. Long-term mortality in HELLP syndrome? Arch Gynecol. maternal and subsequent pregnancy outcomes 5 Obstet., 283(6): 1227-1232. years after hemolysis, elevated liver enzymes and low 15. Liu, C.M., S.D. Chang, et al, 2006. Comparisons of platelets (HELLP) syndrome. American journal of maternal and perinatal outcomes in Taiwanese women Obstetrics and Gynecology, 201(4): 385 e381-385. with complete and partial HELLP syndrome and